Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Carcinoma, Renal Cell 2Renal Insufficiency, Chronic 1Renal Insufficiency 1Kidney Failure, Chronic 1Hematologic Neoplasms 1

Interventions

venetoclax 1saponin QA-21V1 1finerenone 1empagliflozin 1Surveys and Questionnaires 1Stem Cell Transplantation 1Standard of Care 1Specimen Handling 1Resistance Training 1Quillaja Saponins 1Protein Subunit Vaccines 1Practice Guidelines as Topic 1Phlebotomy 1Kidney Transplantation 1High-Energy Shock Waves 1Eplerenone 1Endurance Training 1Breathing Exercises 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Renal Insufficiency, Chronic × Kidney Transplantation × 1 year × Clear all
NCT07358195 2026-01-22

Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation

Massachusetts General Hospital

Phase EARLY_PHASE1 Not yet recruiting
3 enrolled
Other hematologic neoplasm

Hematologic Neoplasms, Renal Insufficiency, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡